Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the UBiT®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms

NCT01623154 is registered in ClinicalTrials.gov with Otsuka America Pharmaceutical as lead sponsor.

NCT NCT01623154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01623154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the UBiT®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Lead sponsor
Otsuka America Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2012
Completion date
April 30, 2013
Enrollment
99 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infection due to helicobacter pylori (h. pylori)